New Zealand Formulary
Menu Close Menu

Fewer cancers.
Better survival.
Equity for all.

Systemic Anti-Cancer Therapy Regimen Library

Home > Gynaecological

Gynaecological Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GYN - pembrolizumab Q3W [flat dosing]
59561000210109
1.0.0
19/08/2022
GYN - pembrolizumab Q3W [weight based dosing]
59581000210101
1.0.0
19/08/2022
GYN - pembrolizumab Q6W [flat dosing]
59571000210103
1.0.0
19/08/2022
GYN Ovarian germ cell tumour - BEP [bleomycin, etoposide and cISplatin]
60221000210103
3.0.0
19/02/2025

Cervical Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GYN CX Advanced - beVACizumab 15 mg/kg Q3W
506561000210109
1.0.0
15/12/2025
GYN CX Advanced - cARBOplatin and PACLItaxel
59531000210100
1.0.0
19/08/2022
GYN CX Advanced - cARBOplatin, PACLItaxel and beVACizumab
59541000210108
1.0.0
19/08/2022
GYN CX Advanced - cARBOplatin, PACLItaxel and pembrolizumab
506251000210108
1.0.0
03/04/2025
GYN CX Advanced - cARBOplatin, PACLItaxel, beVACizumab and pembrolizumab
393731000210102
1.0.0
11/10/2024
GYN CX Advanced - cISplatin and PACLItaxel
59731000210108
1.0.0
29/08/2022
GYN CX Advanced - cISplatin, PACLItaxel and beVACizumab
274651000210101
1.0.0
10/10/2023
GYN CX Advanced - cISplatin, PACLItaxel and pembrolizumab
303441000210103
1.0.0
10/10/2023
GYN CX Advanced - cISplatin, PACLItaxel, beVACizumab and pembrolizumab
303451000210100
1.0.0
23/10/2023
GYN CX Locally advanced - cARBOplatin [Q1W] chemoradiation
59931000210106
1.0.0
20/10/2022
GYN CX Locally advanced - cARBOplatin and PACLItaxel [Q1W] induction followed by cISplatin [Q1W] chemoradiation [INTERLACE]
components ▾
506711000210101
1.0.0
02/03/2026
Part 1: cARBOplatin and PACLItaxel [Q1W] induction
506721000210106
0.0.10
Part 2: cISplatin [Q1W] chemoradiation
506731000210108
0.0.5
GYN CX Locally advanced - cISplatin [Q1W] chemoradiation
59921000210109
2.0.0
13/08/2023
GYN CX Locally advanced - cISplatin [Q1W] chemoradiation and pembrolizumab
506741000210100
1.0.0
02/03/2026

Endometrial Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GYN END Adjuvant - cARBOplatin and PACLItaxel [chemotherapy-only]
60051000210103
2.0.0
13/08/2023
GYN END Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel
components ▾
60071000210106
2.0.0
02/10/2023
Part 1: cISplatin chemoradiation
60081000210108
0.0.5
Part 2: cARBOplatin and PACLItaxel
60091000210105
0.0.5
GYN END Advanced - cARBOplatin and PACLItaxel
59551000210106
1.0.0
19/08/2022
GYN END Advanced - cARBOplatin, PACLItaxel and dostarlimab
496491000210105
1.0.0
20/01/2025
GYN END Advanced - cARBOplatin, PACLItaxel and pembrolizumab
496481000210108
1.0.0
20/01/2025
GYN END Advanced - cARBOplatin, PACLItaxel and trastuzumab
496511000210103
1.0.0
21/01/2025
GYN END Advanced - leNVAtinib and pembrolizumab Q3W [flat dosing]
59661000210108
1.0.0
23/08/2022
GYN END Advanced - meDROXYPROGESTERone acetate
59771000210105
1.0.0
29/08/2022

GTD Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GYN GTD - daCTINomycin [low risk]
59591000210104
1.0.0
23/08/2022
GYN GTD - EMA-CO [etoposide, metHOTREXATe, daCTINomycin - CYCLOPHOSPHamide and vinCRISTine] [high risk]
59911000210104
1.0.0
25/07/2025
GYN GTD - EP [etoposide and cISplatin] [very high risk]
59851000210109
1.0.0
28/09/2022
GYN GTD - EP-EMA [etoposide, ciSplatin - etoposide, metHOTREXATe and daCTINomycin] [high risk]
60011000210102
1.0.0
25/07/2025
GYN GTD - metHOTREXATe [low risk]
59621000210101
1.0.0
19/09/2023
GYN GTD - TP-TE [PACLItaxel, cISplatin - PACLItaxel and etoposide] [relapsed or high risk]
60021000210107
1.0.0
19/09/2023

Ovarian Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GYN OV Adjuvant - cARBOplatin [early stage]
59631000210104
2.0.0
13/08/2023
GYN OV Adjuvant - cARBOplatin and PACLitaxel [early stage]
59641000210107
2.0.0
13/08/2023
GYN OV Advanced - beVACizumab 15 mg/kg Q3W [shared care]
59651000210105
1.0.0
23/08/2022
GYN OV Advanced - beVACizumab 7.5 mg/kg Q3W [shared care]
59761000210104
1.0.0
29/08/2022
GYN OV Advanced - cARBOplatin [primary treatment]
59751000210102
1.0.0
29/08/2022
GYN OV Advanced - cARBOplatin and DOCEtaxel
59721000210106
2.0.0
13/08/2023
GYN OV Advanced - cARBOplatin and PACLItaxel [Q1W]
59711000210101
3.0.0
03/04/2025
GYN OV Advanced - cARBOplatin and PACLitaxel [Q3W]
59701000210103
2.0.0
13/08/2023
GYN OV Advanced - cARBOplatin, PACLItaxel and beVACizumab
59691000210103
2.0.0
02/10/2023
GYN OV Advanced - niraparib
components ▾
393741000210105
1.0.0
11/10/2024
niraparib 200 mg
393751000210108
0.0.3
niraparib 300 mg
393761000210106
0.0.4
GYN OV Advanced - olaparib
59671000210102
1.0.0
29/08/2022
GYN OV Low grade serous carcinoma - letrozole maintenance
60001000210104
1.0.0
20/10/2022
GYN OV Low grade serous carcinoma - tRAMEtinib
506751000210102
1.0.0
02/03/2026
GYN OV Recurrent - cARBOplatin
59681000210100
1.0.0
29/08/2022
GYN OV Recurrent - cARBOplatin and gemcitabine [day 1 cARBOplatin]
59891000210102
1.0.0
28/09/2022
GYN OV Recurrent - cARBOplatin and pegylated liposomal DOXOrubicin hydrochloride
59881000210104
1.0.0
28/09/2022
GYN OV Recurrent - cARBOplatin, gemcitabine and beVACizumab
59871000210101
1.0.0
28/09/2022
GYN OV Recurrent - cARBOplatin, pegylated liposomal DOXOrubicin hydrochloride and beVACizumab
59861000210107
1.0.0
28/09/2022
GYN OV Recurrent - CYCLOPHOSPHamide oral [2/4 dosing]
59991000210107
1.0.0
20/10/2022
GYN OV Recurrent - CYCLOPHOSPHamide oral [continuous]
59981000210105
1.0.0
20/10/2022
GYN OV Recurrent - etoposide oral
59971000210108
1.0.0
20/10/2022
GYN OV Recurrent - gemcitabine
59961000210102
1.0.0
20/10/2022
GYN OV Recurrent - PACLitaxel [Q1W]
60201000210106
2.0.0
03/04/2025
GYN OV Recurrent - PACLitaxel [Q1W] and beVACizumab
60211000210108
2.0.0
03/04/2025
GYN OV Recurrent - pegylated liposomal DOXOrubicin hydrochloride
59951000210100
1.0.0
20/10/2022
GYN OV Recurrent - pegylated liposomal DOXOrubicin hydrochloride and beVACizumab
59941000210103
1.0.0
20/10/2022
GYN OV Recurrent - topotecan
60061000210100
1.0.0
28/10/2022
GYN OV Recurrent - topotecan and beVACizumab Q4W
60031000210109
1.0.0
28/10/2022

Vulval Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
GYN VUL Advanced - CARBOplatin [Q1W] chemoradiation
60041000210101
1.0.0
28/10/2022
GYN VUL Advanced - ciSplatin [Q1W] chemoradiation
264761000210100
1.0.0
10/07/2023